Cargando…
Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy
[Image: see text] Metallonitrosyl complexes are promising as nitric oxide (NO) donors for the treatment of cardiovascular, endothelial, and pathogenic diseases, as well as cancer. Recently, the reduced form of NO(–) (protonated as HNO, nitroxyl, azanone, isoelectronic with O(2)) has also emerged as...
Autores principales: | Silva Sousa, Eduardo Henrique, Ridnour, Lisa A., Gouveia, Florêncio S., Silva da Silva, Carlos Daniel, Wink, David A., de França Lopes, Luiz Gonzaga, Sadler, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949585/ https://www.ncbi.nlm.nih.gov/pubmed/27191177 http://dx.doi.org/10.1021/acschembio.6b00222 |
Ejemplares similares
-
H(2)S/Thiols, NO(•), and
NO(–)/HNO: Interactions with Iron Porphyrins
por: Bieza, Silvina, et al.
Publicado: (2022) -
Kinetics of Azanone (HNO) Reactions with Thiols: Effect of pH
por: Smulik-Izydorczyk, Renata, et al.
Publicado: (2021) -
HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCε Activation
por: Mancardi, Daniele, et al.
Publicado: (2022) -
The Effects of Nitroxyl (HNO) on Soluble Guanylate Cyclase Activity: INTERACTIONS AT FERROUS HEME AND CYSTEINE THIOLS
por: Miller, Thomas W., et al.
Publicado: (2009) -
HNO/NO
Conversion Mechanisms of Cu-Based HNO Probes
with Implications for Cu,Zn-SOD
por: Michael, Matthew A., et al.
Publicado: (2014)